|
|
|
|
|
|
|
||
Commentaries |
Cells within the DC lineage of white blood cells are the sentinels of the immune system, the most potent of APCs; at various ports of entry, they specialize in capturing antigens and stimulating T cell–associated immunity (1–3). DCs regulate the activation of T cells not only by efficiently processing and presenting immunogenic peptides in association with self-MHC (1–4), but also via expression of coreceptor molecules such as CD80 and CD86 (5–7) and the production of cytokines such as IL-12 (8–11).
Although a role for DCs in the activation of T cells is well established, it is less clear to what extent DCs regulate other cells. It is known that DCs are essential for the development of antibody responses (12–15), but this has been thought to be simply a secondary consequence of the requirement for DCs to activate naive helper T cells. Now several recent findings suggest that DCs may directly regulate B cell maturation. In this issue of the Journal of Experimental Medicine Dubois et al. (16) report that small numbers (250–1,000 cells) of highly purified CD1a+ dendritic–Langerhans cells (D–Lc) can directly stimulate activated B cells both to proliferate and produce significant amounts of IgM or IgG. This dramatic effect is dependent on the B cells being stimulated through CD40 receptors. Of the B cell populations tested, IgG- and IgA-producing memory B cells are the most responsive to D–Lcs, but IgD+ B cells can also be stimulated by DCs to produce IgM in vitro.
How might DCs directly induce B cell maturation? DCs and B cells both constitutively express CD40 and class II, and both, in response to certain cytokines, LPS or CD40 ligation, upregulate surface CD54 (ICAM-1), CD80, and CD86 (4, 7, 10, 17–19). And both DCs and B cells can engage T cells in reciprocal dialogues (19), during which both the T cell and APC are activated via either cell–cell interaction molecules or locally secreted cytokines. Thus, it is likely that some type of reciprocal signaling also occurs between DCs and B cells.
Although the DC-dependent B cell proliferation described by Dubois et al. (16) could be mediated by a soluble factor, optimal induction of antibody production by DCs required both cell–cell contact, soluble factors, and activation of DCs via their CD40 receptors. Stimulation via CD40 has a number of effects on DCs including preventing them from dying (20); so one possibility is that some kind of rescue signal may be required to keep DCs alive in long-term 15-d cultures with B cells. CD40 ligation also induces DCs (and B cells) to express functional CD40L (21), and CD40L+ DCs can stimulate B cells directly to secrete IgG and IgA via a CD40L-dependent pathway (21). Thus, some or all of the cell–cell contact requirement for DC-dependent antibody production may be mediated by CD40L–CD40 signaling. The fact that DCs and B cells can be seen clustered in close contact (16) suggests that as much remains to be learned about DC–B cell and DC-T-B interactions as remained for DC-T interactions after DCs and T cells were first found clustered together (12–14). One intriguing possibility is that B cells in close proximity with DCs may compete for signals from T cells (such as CD40L) and thereby influence the type or degree of cytokines made by DCs (22).
Relatively little is known about the range of cytokines or chemokines made by cells in the DC lineage, let alone which of them may regulate B cells. Although IL-12 is secreted by DCs after CD40 ligation (9, 10), it probably has no direct effect on resting or activated B cells, which do not express IL-12 receptors (23). DCs or DC-related cell lines have been reported to make IL-1, IL-6, and TNF-
The recent in vitro studies of DC–B cell interactions (16, 21) leave unanswered a critical question: Where might a DC stimulate a B cell in vivo? Dubois and coworkers point out that after challenge with antigen, T cell–dependent B cell activation and maturation occurs within extrafollicular regions of peripheral lymphoid tissues (32–34). So one likely sequence is that DCs process antigen, migrate to the T cell zones in peripheral lymphoid tissues and there both activate naive T cells and are activated by T cells (1, 4, 17). Antigen-specific B cells in these T cell regions then could form clusters with T cells and their associated DCs (13, 14) and receive signals from both cell types. Since both T cells and B cells enter the spleen through marginal zones (35) and most CD40L+ T cells are found within periarteriolar lymphoid sheaths (PALS) (36), it would be interesting to know whether or not during an immune response B cells actually associate with DCs in these regions, e.g., along the outer edge of the PALS as they migrate into primary follicles.
Another potential site where DCs might encounter and regulate B cells is the germinal center (GC). It had been thought that DCs in lymphoid tissues, such as interdigitating DCs, are relatively restricted to T cell zones. However, GCs also contain specialized CD4+ CD11c+ DCs, designated GCDCs (37), which as potent activators of T cells may function to sustain GC memory T cells or promote T–B interactions within germinal centers. Although Grouard et al. (37) suggest that GCDCs most likely function by stimulating GC T cells, they also show that GCDCs express both complement and Fc receptors opening the possibility that immune complexes on GCDCs may regulate GC memory B cells. While germinal centers persist for only
(e.g., 2, 24–27), all of which can promote B cell maturation (28). The types of chemokines DC lineage cells can make such as macrophage inflammatory protein-1 gamma (29) are just beginning to be defined. It will be important to compare CD1a+ versus CD1a– DCs for their ability to make known B cell-stimulating factors such as IL-11 and chemokines as well as to assess whether B cells produce factors that can regulate or attract DCs (30, 31). 
3 wk after immunization, memory B blasts continue to proliferate in follicles for months after the onset of T cell–dependent antibody responses (32). These cells are probably the source of plasma cells and memory cells required to maintain longterm antibody production and could well be regulated by GCDCs. Follicular B cells can be induced to differentiate into plasmablasts by signals such as IL-1 (32, 38), which DCs can produce. Furthermore, some plasmablasts and plasma cells express CD28 (39); thus, GCDCs (37) and other DCs that can express CD80/86 might be able to sustain or stimulate CD28+ plasmablasts through the CD28 pathway. Clearly, much remains to be done beyond these suggestive studies (16, 21, 37) to define the molecular mechanisms involved in DC–B cell interactions and their roles in human diseases involving dysregulated B cells such as lymphomas and autoimmune diseases.
 |
Acknowledgments |
|---|
Submitted: 16 January 1997
|
References |
|---|
 Top References |
|---|
1 Steinman RM. The dendritic cell system and its role in immunogenicity, Annu Rev Immunol, 1991, 9, 271–296.[Medline]
2 Banchereau, J., and D. Schmitt. 1995. Dendritic cells in fundamental and clinical immunology. Vol. 2. Plenum Press, New York. 572 pp.
3 Stingl G & Bergstresser P R. Dendritic cells: a major story unfolds, Immunol Today, 1995, 16, 330–333.[Medline]
4 Sallusto F, Cella M, Danieli C & Lanzavecchia A. Dendritic cells use macropinocytosis and the mannose receptor to concentrate macromolecules in the major histocompatibility complex class II compartment: downregulation by cytokines and bacterial products , J Exp Med, 1995, 182, 389–400.
5 Inaba K, Witmer-Pack M, Inaba M, Hathcock KS, Sakuta H, Azuma M, Yagita H, Okumura K, Linsley PS, Ikehara S, Muramatsu S, Hodes RJ & Steinman RM. The tissue distribution of the B7-2 costimulator in mice: abundant expression on dendritic cells in situ and during maturation in vitro, J Exp Med, 1994, 180, 1849–1860.
6 Caux C, Vanbervliet B, Massacrier C, Azuma M, Okumura K, Lanier LL & Banchereau J. B70/B7-2 is identical to CD86 and is the major functional ligand for CD28 expressed on human dendritic cells, J Exp Med, 1994, 180, 1841–1847.
7 Pinchuk LM, Polacino PS, Agy MB, Klaus SJ & Clark EA. Role of CD40 and CD80 accessory cell molecules in dendritic cell-dependent HIV-1 infection, Immunity, 1994, 1, 317–325.[Medline]
8 Macatonia SE, Hosken NA, Litton M, Vieira P, Hsieh CS, Culpepper JA, Wysocka M, Trinchieri G, Murphy KM & O'Garra A. Dendritic cells produce IL-12 and direct the development of Th1 cells from naive CD4+ T cells, J Immunol, 1995, 154, 5071–5079.[Abstract]
9 Koch F, Stanzl U, Jennewein P, Janke K, Heufler C, Kampgen E, Romani N & Schuler G. High level IL-12 production by murine dendritic cells: upregulation via MHC class II and CD40 molecules and downregulation by IL-4 and IL-10, J Exp Med, 1996, 184, 741–746.
10 Cella M, Scheidegger D, Palmer-Lehmann K, Lane P, Lanzavecchia A & Alber G. Ligation of CD40 on dendritic cells triggers production of high levels of interleukin-12 and enhances T cell stimulatory capacity: T-T help via APC activation, J Exp Med, 1996, 184, 747–752.
11 Heufler C, Koch F, Stanzl U, Topar G, Wysocka M, Trinchieri G, Enk A, Steinman RM, Romaniand N & Schuler G. Interleukin-12 is produced by dendritic cells and mediates T helper 1 development as well as interferongamma production by T helper 1 cells, Eur J Immunol, 1996, 26, 659–668.[Medline]
12 Inaba K, Steinman RM, Van Voorhis WC & Muramatsu S. Dendritic cells are critical accessory cells for thymus-dependent antibody responses in mouse and in man, Proc Natl Acad Sci USA, 1983, 80, 6041–6045.
13 Inaba K, Witmer MD & Steinman RM. Clustering of dendritic cells, helper T lymphocytes, and histocompatible B cells during primary antibody responses in vitro, J Exp Med, 1984, 160, 858–876.
14 Inaba K & Steinman RM. Protein-specific helper T-lymphocyte formation initiated by dendritic cells, Science (Wash DC), 1985, 229, 475–479.
15 Sornasse T, Flamand V, De Becker G, Bazin H, Tielemans F, Thielemans K, Urbain J, Leo O & Moser M. Antigen-pulsed dendritic cells can efficiently induce an antibody response in vivo, J Exp Med, 1992, 175, 15–21.
16 Dubois B, Vanbervliet B, Fayette J, Massacrier C, Van Kooten C, Briere F, Banchereau J & Caux C. Dendritic cells enhance growth and differentiation of CD40-activated B lymphocytes, J Exp Med, 1997, 185, 941–951.
17 Sallusto F & Lanzavecchia A. Efficient presentation of soluble antigen by cultured human dendritic cells is maintained by granulocyte/macrophage colony-stimulating factor plus interleukin 4 and downregulated by tumor necrosis factor alpha, J Exp Med, 1994, 179, 1109–1118.
18 Caux C, Massacrier C, Vanbervliet B, Dubois B, Van KC, Durand I & Banchereau J. Activation of human dendritic cells through CD40 cross-linking, J Exp Med, 1994, 180, 1263–1272.
19 Clark EA & Ledbetter JA. How B and T cells talk to each other, Nature (Lond), 1994, 367, 425–428.[Medline]
20 Ludewig B, Graf D, Gelderblom HR, Becker Y, Kroczek RA & Pauli G. Spontaneous apoptosis of dendritic cells is efficiently inhibited by TRAP (CD40-ligand) and TNF-alpha, but strongly enhanced by interleukin-10, Eur J Immunol, 1995, 25, 1943–1950.[Medline]
21 Pinchuk LM, Klaus SJ, Magaletti DM, Pinchuk GV, Norsen JP & Clark EA. Functional CD40 ligand (CD40L) expressed by human blood dendritic cells is upregulated by CD40 ligation, J Immunol, 1996, 157, 4363–4370.[Abstract]
22 Maruo S, Oh-hora M, Ahn H-J, Ono S, Wysocka M, Kaneko Y, Yagita H, Okumura K, Kikutani H, Kishimoto T et al.. B cells regulate CD40 ligand-induced IL-12 production in antigen-presenting cells (APC) during T cell/APC interactions, J Immunol, 1997, 158, 120–126.[Abstract]
23 Desai BB, Quinn PM, Wolitzky AG, Mongini PK, Chizzonite R & Gately MK. IL-12 receptor. II. Distribution and regulation of receptor expression, J Immunol, 1992, 148, 3125–3132.[Abstract]
24 Romani N, Kampgen E, Koch F, Heufler C & Schuler G. Dendritic cell production of cytokines and responses to cytokines, Int Rev Immunol, 1990, 6, 151–161.[Medline]
25 Heufler C, Topar G, Koch F, Trockenbacher B, Kampgen E, Romani N & Schuler G. Cytokine gene expression in murine epidermal cell suspensions: interleukin 1 beta and macrophage inflammatory protein 1 alpha are selectively expressed in Langerhans cells but are differentially regulated in culture, J Exp Med, 1992, 176, 1221–1226.
26 Zhou LJ & Tedder TF. A distinct pattern of cytokine gene expression by human CD83+ blood dendritic cells, Blood, 1995, 86, 3295–3301.
27 Kanangat S, Nair S, Babu JS & Rouse BT. Expression of cytokine mRNA in murine splenic dendritic cells and better induction of T cell-derived cytokines by dendritic cells than by macrophages during in vitro costimulation assay using specific antigens, J Leukoc Biol, 1995, 57, 310–316.[Abstract]
28 Akira ST, Hirano, Taga T & Kishimoto T. Biology of multifunctional cytokines: IL 6 and related molecules (IL 1 and TNF), FASEB J, 1990, 4, 2860–2867.[Abstract]
29 Mohamadzadeh M, Poltorak AN, Bergstressor PR, Beutler B & Takashima A. Dendritic cells produce macrophage inflammatory protein-1 gamma, a new member of the CC chemokine family, J Immunol, 1996, 156, 3102–3106.[Abstract]
30 Xu LL, Warren MK, Rose WL, Gong W & Wang JM. Human recombinant monocyte chemotactic protein and other C-C chemokines bind and induce directional migration of dendritic cells in vitro, J Leukoc Biol, 1996, 60, 365–371.[Abstract]
31 Sozzani S, Sallusto F, Luini W, Zhou D, Piemonti L, Allavena P, Van Damme J, Valitutti S, Lanzavecchia A & Mantovani A. Migration of dendritic cells in response to formyl peptides, C5a, and a distinct set of chemokines, J Immunol, 1995, 155, 3292–3295.[Abstract]
32 Kelsoe G & Zheng B. Sites of B cell activation in vivo, Cur Opin Immunol, 1993, 5, 418–422.[Medline]
33 MacLennan IC. Germinal centers, Annu Rev Immunol, 1994, 12, 117–139.[Medline]
34 Liu YJ & Banchereau J. The paths and molecular controls of peripheral B-cell development, The Immunologist, 1996, 4, 55–66.
35 Nieuwenhuis P & Ford WL. Comparative migration of B and T lymphocytes in the rat spleen and lymph nodes, Cell Immunol, 1976, 23, 254–267.[Medline]
36 van den Eertwegh AJ, Laman JD, Noelle RJ, Boersma WJ & Claassen E. In vivo T-B cell interactions and cytokine-production in the spleen, Semin Immunol, 1994, 6, 327–336.[Medline]
37 Grouard G, Durnad I, Filgueira L, Banchereau J & Liu Y-J. Dendritic cells capable of stimulating T cells in germinal centres, Nature (Lond), 1996, 384, 364–367.[Medline]
38 van Rooijen N. Direct intrafollicular differentiation of memory B cells into plasma cells, Immunol Today, 1990, 11, 154–157.[Medline]
39 Kozbor D, Moretta A, Messner HA, Moretta L & Croce CM. Tp44 molecules involved in antigen-independent T cell activation are expressed on human plasma cells, J Immunol, 1987, 138, 4128–4132.[Abstract]
CiteULike 
Complore 
Connotea 
Del.icio.us 
Digg 
Facebook 
Reddit 
Technorati 
Twitter What's this?
This article has been cited by other articles:
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| TABLE OF CONTENTS |
|
